Literature DB >> 7743662

Dichotomy of the T cell response to Leishmania antigens in patients suffering from cutaneous leishmaniasis; absence or scarcity of Th1 activity is associated with severe infections.

A Gaafar1, A Kharazmi, A Ismail, M Kemp, A Hey, C B Christensen, M Dafalla, A Y el Kadaro, A M el Hassan, T G Theander.   

Abstract

The T cell response was studied in 25 patients suffering from cutaneous leishmaniasis caused by Leishmania major with severe (n = 10) and mild (n = 15) disease manifestations. Peripheral blood mononuclear cells (PBMC) from the patients were activated by sonicates of Leishmania promastigotes (LMP) and amastigotes (LDA), and the surface protease gp63. The proliferative responses to Leishmania antigens were lower in patients with severe disease than in patients with mild disease (P = 0.01-0.05), and such a difference was not observed in the response to purified protein derivative of tuberculin (PPD) or tetanus toxoid (TT). LMP-induced interferon-gamma (IFN-gamma) production was lower in patients with severe than in patients with mild disease (P < 0.05). When the IL-4 and IFN-gamma responses of each patient were considered, two response patterns were observed in the cultures activated by the Leishmania sonicates. One response pattern was characterized by high production of IFN-gamma without production of IL-4 (a Th1-like pattern), the other was characterized by low IFN-gamma levels which in most cases were associated with IL-4 production (not a Th1-like pattern). These patterns could not be distinguished when the cells from the same donors were stimulated by TT and PPD. The percentages of patients with a Th1-like response pattern after stimulation by LMP in patients with severe and mild disease manifestations were 30% and 80%, respectively. This difference was statistically significant (P = 0.034).

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7743662      PMCID: PMC1534327          DOI: 10.1111/j.1365-2249.1995.tb03660.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  34 in total

1.  Studies on the leishmaniases in the Sudan. 2. Clinical and parasitological studies on cutaneous leishmaniasis.

Authors:  S H el-Safi; W Peters; B el-Toam; A el-Kadarow; D A Evans
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Jul-Aug       Impact factor: 2.184

2.  A new portable device for automatic controlled-gradient cryopreservation of blood mononuclear cells.

Authors:  L Hviid; G Albeck; B Hansen; T G Theander; A Talbot
Journal:  J Immunol Methods       Date:  1993-01-04       Impact factor: 2.303

3.  Prevalence of cutaneous leishmaniasis along the Nile River north of Khartoum (Sudan) in the aftermath of an epidemic in 1985.

Authors:  A Y Kadaro; H W Ghalib; M S Ali; I Eltoum; A Ismail; A Gaafar; M Kemp; A A Kordofani; S G Reed; A M el-Hassan
Journal:  Am J Trop Med Hyg       Date:  1993-01       Impact factor: 2.345

4.  In vivo cytokine profiles in patients with kala-azar. Marked elevation of both interleukin-10 and interferon-gamma.

Authors:  C L Karp; S H el-Safi; T A Wynn; M M Satti; A M Kordofani; F A Hashim; M Hag-Ali; F A Neva; T B Nutman; D L Sacks
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

5.  Measurement of antigen-dependent interleukin-4 production by human peripheral blood mononuclear cells. Introduction of an amplification step using ionomycin and phorbol myristate acetate.

Authors:  J A Kurtzhals; M B Hansen; A S Hey; L K Poulsen
Journal:  J Immunol Methods       Date:  1992-12-08       Impact factor: 2.303

6.  Recognition of Leishmania antigens by T lymphocytes from nonexposed individuals.

Authors:  M Kemp; M B Hansen; T G Theander
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

7.  Leishmania donovani-reactive Th1- and Th2-like T-cell clones from individuals who have recovered from visceral leishmaniasis.

Authors:  M Kemp; J A Kurtzhals; K Bendtzen; L K Poulsen; M B Hansen; D K Koech; A Kharazmi; T G Theander
Journal:  Infect Immun       Date:  1993-03       Impact factor: 3.441

8.  Cytokine patterns in the pathogenesis of human leishmaniasis.

Authors:  C Pirmez; M Yamamura; K Uyemura; M Paes-Oliveira; F Conceição-Silva; R L Modlin
Journal:  J Clin Invest       Date:  1993-04       Impact factor: 14.808

9.  Contribution of non-Leishmania-specific immunity to resistance to Leishmania infection in humans.

Authors:  H O Akuffo; S F Britton
Journal:  Clin Exp Immunol       Date:  1992-01       Impact factor: 4.330

10.  Determination of the cytokine profile in American cutaneous leishmaniasis using the polymerase chain reaction.

Authors:  G Cáceres-Dittmar; F J Tapia; M A Sánchez; M Yamamura; K Uyemura; R L Modlin; B R Bloom; J Convit
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

View more
  9 in total

1.  Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals.

Authors:  P Tripathi; S Ray; S Sunder; A Dube; S Naik
Journal:  Clin Exp Immunol       Date:  2006-02       Impact factor: 4.330

2.  Leishmania-specific T cells expressing interferon-gamma (IFN-gamma) and IL-10 upon activation are expanded in individuals cured of visceral leishmaniasis.

Authors:  K Kemp; M Kemp; A Kharazmi; A Ismail; J A Kurtzhals; L Hviid; T G Theander
Journal:  Clin Exp Immunol       Date:  1999-06       Impact factor: 4.330

3.  Combination therapy with paromomycin-associated stearylamine-bearing liposomes cures experimental visceral leishmaniasis through Th1-biased immunomodulation.

Authors:  Antara Banerjee; Manjarika De; Nahid Ali
Journal:  Antimicrob Agents Chemother       Date:  2011-01-10       Impact factor: 5.191

4.  High levels of plasma IL-10 and expression of IL-10 by keratinocytes during visceral leishmaniasis predict subsequent development of post-kala-azar dermal leishmaniasis.

Authors:  S Gasim; A M Elhassan; E A Khalil; A Ismail; A M Kadaru; A Kharazmi; T G Theander
Journal:  Clin Exp Immunol       Date:  1998-01       Impact factor: 4.330

5.  Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

Authors:  S Ajdary; M H Alimohammadian; M B Eslami; K Kemp; A Kharazmi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

6.  In situ immunopathological changes in cutaneous leishmaniasis due to Leishmania donovani.

Authors:  N H Manamperi; S Oghumu; N Pathirana; M V C de Silva; W Abeyewickreme; A R Satoskar; N D Karunaweera
Journal:  Parasite Immunol       Date:  2017-03       Impact factor: 2.280

Review 7.  Cytokines: Key Determinants of Resistance or Disease Progression in Visceral Leishmaniasis: Opportunities for Novel Diagnostics and Immunotherapy.

Authors:  Alti Dayakar; Sambamurthy Chandrasekaran; Suresh V Kuchipudi; Suresh K Kalangi
Journal:  Front Immunol       Date:  2019-04-05       Impact factor: 7.561

Review 8.  A Historic Review of the Role of CD4+ T-Cell Subsets in Development of the Immune Responses against Cutaneous and Visceral Leishmaniases

Authors:  Mohammad Hossein Alimohmmadian; Soheila Ajdary; Fariborz Bahrami
Journal:  Iran Biomed J       Date:  2022-03-01

9.  Cellular Markers of Active Disease and Cure in Different Forms of Leishmania infantum-Induced Disease.

Authors:  Laura Botana; Belén Matía; Juan V San Martin; Alberto Romero-Maté; Alicia Castro; Laura Molina; Laura Fernandez; Ana Ibarra-Meneses; Marta Aguado; Carmen Sánchez; Luis Horrillo; Carmen Chicharro; Javier Nieto; Sheila Ortega; José Manuel Ruiz-Giardin; Eugenia Carrillo; Javier Moreno
Journal:  Front Cell Infect Microbiol       Date:  2018-11-13       Impact factor: 5.293

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.